Literature DB >> 24418536

HPV16 infection of HaCaTs is dependent on β4 integrin, and α6 integrin processing.

Pınar Aksoy1, Cynthia Y Abban1, Elizabeth Kiyashka1, Weitao Qiang1, Patricio I Meneses2.   

Abstract

Our understanding of human papillomavirus (HPV) is still evolving. To further study the field, our laboratory has focused on determining the role of integrins in the initial steps of viral endocytosis into HaCaT cells. Our and others' previous findings have shown that α6 is necessary for infection. Here we show that α3 and β1 were dispensable, and we identified integrin α6β4 complex as necessary for infection in HaCaTs. β4 knock down resulted in a significant decrease in HPV16 PsV infection and perhaps most importantly resulted in defective post-translational α6 processing. We showed that the unprocessed α6 does not localize to the cell surface. We propose that the α6β4 complex is necessary for the formation of an endocytic complex that results in the signaling transduction events necessary for initial endocytosis.
© 2013 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  HPV; HaCaTs; Virus entry; α6 Integrin; β4 Integrin

Mesh:

Substances:

Year:  2013        PMID: 24418536      PMCID: PMC4046336          DOI: 10.1016/j.virol.2013.10.034

Source DB:  PubMed          Journal:  Virology        ISSN: 0042-6822            Impact factor:   3.616


  29 in total

1.  Endoproteolytic processing of integrin pro-alpha subunits involves the redundant function of furin and proprotein convertase (PC) 5A, but not paired basic amino acid converting enzyme (PACE) 4, PC5B or PC7.

Authors:  J C Lissitzky; J Luis; J S Munzer; S Benjannet; F Parat; M Chrétien; J Marvaldi; N G Seidah
Journal:  Biochem J       Date:  2000-02-15       Impact factor: 3.857

2.  α6β4 integrin, a master regulator of expression of integrins in human keratinocytes.

Authors:  Kristina R Kligys; Yvonne Wu; Susan B Hopkinson; Surinder Kaur; Leonidas C Platanias; Jonathan C R Jones
Journal:  J Biol Chem       Date:  2012-04-06       Impact factor: 5.157

3.  Usage of heparan sulfate, integrins, and FAK in HPV16 infection.

Authors:  Cynthia Y Abban; Patricio I Meneses
Journal:  Virology       Date:  2010-05-02       Impact factor: 3.616

4.  Use of an in vivo animal model for assessing the role of integrin α(6)β(4) and syndecan-1 in early steps in papillomavirus infection.

Authors:  Hao-Shun Huang; Paul F Lambert
Journal:  Virology       Date:  2012-09-18       Impact factor: 3.616

Review 5.  The biology and therapeutic targeting of the proprotein convertases.

Authors:  Nabil G Seidah; Annik Prat
Journal:  Nat Rev Drug Discov       Date:  2012-05       Impact factor: 84.694

6.  Role of heparan sulfate in attachment to and infection of the murine female genital tract by human papillomavirus.

Authors:  Katherine M Johnson; Rhonda C Kines; Jeffrey N Roberts; Douglas R Lowy; John T Schiller; Patricia M Day
Journal:  J Virol       Date:  2008-12-10       Impact factor: 5.103

7.  Human papillomavirus type 16 infection of human keratinocytes requires clathrin and caveolin-1 and is brefeldin a sensitive.

Authors:  Valerie Laniosz; Sarah A Dabydeen; Mallory A Havens; Patricio I Meneses
Journal:  J Virol       Date:  2009-06-03       Impact factor: 5.103

8.  Essential roles for soluble virion-associated heparan sulfonated proteoglycans and growth factors in human papillomavirus infections.

Authors:  Zurab Surviladze; Agnieszka Dziduszko; Michelle A Ozbun
Journal:  PLoS Pathog       Date:  2012-02-09       Impact factor: 6.823

9.  Target cell cyclophilins facilitate human papillomavirus type 16 infection.

Authors:  Malgorzata Bienkowska-Haba; Hetalkumar D Patel; Martin Sapp
Journal:  PLoS Pathog       Date:  2009-07-24       Impact factor: 6.823

10.  The S100A10 subunit of the annexin A2 heterotetramer facilitates L2-mediated human papillomavirus infection.

Authors:  Andrew W Woodham; Diane M Da Silva; Joseph G Skeate; Adam B Raff; Mark R Ambroso; Heike E Brand; J Mario Isas; Ralf Langen; W Martin Kast
Journal:  PLoS One       Date:  2012-08-22       Impact factor: 3.240

View more
  14 in total

1.  Superinfection Exclusion between Two High-Risk Human Papillomavirus Types during a Coinfection.

Authors:  Jennifer Biryukov; Craig Meyers
Journal:  J Virol       Date:  2018-03-28       Impact factor: 5.103

2.  A Dual Role for the Nonreceptor Tyrosine Kinase Pyk2 during the Intracellular Trafficking of Human Papillomavirus 16.

Authors:  Elinor Y Gottschalk; Patricio I Meneses
Journal:  J Virol       Date:  2015-06-24       Impact factor: 5.103

Review 3.  HPV entry into cells.

Authors:  Pinar Aksoy; Elinor Y Gottschalk; Patricio I Meneses
Journal:  Mutat Res Rev Mutat Res       Date:  2016-09-23       Impact factor: 5.657

4.  How non-enveloped viruses hijack host machineries to cause infection.

Authors:  Chelsey C Spriggs; Mara C Harwood; Billy Tsai
Journal:  Adv Virus Res       Date:  2019-07-02       Impact factor: 9.937

5.  Furin Cleavage of L2 during Papillomavirus Infection: Minimal Dependence on Cyclophilins.

Authors:  Matthew P Bronnimann; Christine M Calton; Samantha F Chiquette; Shuaizhi Li; Mingfeng Lu; Janice A Chapman; Kristin N Bratton; Angela M Schlegel; Samuel K Campos
Journal:  J Virol       Date:  2016-06-24       Impact factor: 5.103

6.  Remodeling of extracellular matrix by normal and tumor-associated fibroblasts promotes cervical cancer progression.

Authors:  Alexandra Fullár; József Dudás; Lászlóné Oláh; Péter Hollósi; Zoltán Papp; Gábor Sobel; Katalin Karászi; Sándor Paku; Kornélia Baghy; Ilona Kovalszky
Journal:  BMC Cancer       Date:  2015-04-11       Impact factor: 4.430

Review 7.  How DNA and RNA Viruses Exploit Host Chaperones to Promote Infection.

Authors:  Kaitlyn Speckhart; Jeffrey M Williams; Billy Tsai
Journal:  Viruses       Date:  2021-05-21       Impact factor: 5.048

Review 8.  Papillomavirus Infectious Pathways: A Comparison of Systems.

Authors:  Jennifer Biryukov; Craig Meyers
Journal:  Viruses       Date:  2015-08-04       Impact factor: 5.048

Review 9.  Human papillomavirus induced transformation in cervical and head and neck cancers.

Authors:  Allie K Adams; Trisha M Wise-Draper; Susanne I Wells
Journal:  Cancers (Basel)       Date:  2014-09-15       Impact factor: 6.639

10.  Griffithsin and Carrageenan Combination To Target Herpes Simplex Virus 2 and Human Papillomavirus.

Authors:  Keith Levendosky; Olga Mizenina; Elena Martinelli; Ninochka Jean-Pierre; Larisa Kizima; Aixa Rodriguez; Kyle Kleinbeck; Thierry Bonnaire; Melissa Robbiani; Thomas M Zydowsky; Barry R O'Keefe; José A Fernández-Romero
Journal:  Antimicrob Agents Chemother       Date:  2015-09-14       Impact factor: 5.191

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.